Of interest, E2F1 has been reported to function as a critical antiapoptotic factor in human and rodent liver cancer via activation of the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway [13]. The gene discussed is MTOR; the disease is liver cancer.